SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-255338
Filing Date
2011-09-23
Accepted
2011-09-23 16:40:42
Documents
4
Period of Report
2011-09-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d235665d8k.htm 8-K 42489
2 EX-4.1 d235665dex41.htm EX-4.1 283743
3 EX-99.1 d235665dex991.htm EX-99.1 8877
4 GRAPHIC g235665ex99_1pg001.jpg GRAPHIC 16050
  Complete submission text file 0001193125-11-255338.txt   358850
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1370 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1370 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 111105507
SIC: 2834 Pharmaceutical Preparations